Revenue and Adjusted EBITDA In Line with Guidance
Net revenue of $19.0M for Q1 FY2026 (midpoint of guidance) and adjusted EBITDA of $1.4M, both within guided ranges.
AI-Related Demand Strength
AI-related products accounted for ~35% of Thermal Processing Solutions (TPS) revenue in Q1, up from ~30% in Q4 (approximately a 10% sequential increase in AI revenue contribution). Management expects AI demand to continue into Q3–Q4 and drive the majority of anticipated revenue growth.
Strong Bookings and Book-to-Bill
Bookings were strong in the quarter with an overall book-to-bill ratio of 1.1, driven by TPS and AI equipment orders; company can deliver most equipment in Q2 though some customer requests pushed deliveries into Q3.
Margin Improvement Despite Lower Volume
Consolidated gross margin expanded to 44.8% in Q1 FY2026 versus 38.4% in the year-ago quarter (up 6.4 percentage points YoY) and 44.4% in Q4 (up 0.4 ppt sequential), achieved on lower sales volume following product-line rationalization and semi-fabless model adoption.
Cash Generation and Balance Sheet Strength
Operating cash flow was positive for the ninth consecutive quarter at $4.1M; unrestricted cash rose to $22.1M (no debt). Cash increased by $8.9M (67%) over the trailing 12 months to 12/31/2025.
Strategic Wins: Panel-Level Packaging and Specialty Chemicals
Received initial orders from multiple industry leaders for emerging panel-level packaging equipment (validating future addressable market), and achieved first win and initial delivery for a specialty chemical product targeting medical device semiconductor application.
Operational Transformation and Low Capital Intensity
Shift to a semi-fabless manufacturing model and consolidation of facilities from seven to four is expected to enable revenue scalability with minimal capex (2026 capex expected below $1M), supporting operating leverage and higher future gross margins.
Improved Recurring Revenue Pipeline
Improved bookings in services businesses (Intrifix and BTU parts/services) and a growing pipeline for specialty chemicals, which management expects to produce double-digit growth and meaningful profits beyond 2026.